1. Home
  2. IVA vs HLLY Comparison

IVA vs HLLY Comparison

Compare IVA & HLLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • HLLY
  • Stock Information
  • Founded
  • IVA 2011
  • HLLY 1903
  • Country
  • IVA France
  • HLLY United States
  • Employees
  • IVA N/A
  • HLLY N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • HLLY Auto Parts:O.E.M.
  • Sector
  • IVA Health Care
  • HLLY Consumer Discretionary
  • Exchange
  • IVA Nasdaq
  • HLLY Nasdaq
  • Market Cap
  • IVA 359.6M
  • HLLY 353.7M
  • IPO Year
  • IVA 2020
  • HLLY N/A
  • Fundamental
  • Price
  • IVA $3.01
  • HLLY $2.26
  • Analyst Decision
  • IVA Strong Buy
  • HLLY Strong Buy
  • Analyst Count
  • IVA 4
  • HLLY 6
  • Target Price
  • IVA $10.50
  • HLLY $5.21
  • AVG Volume (30 Days)
  • IVA 18.3K
  • HLLY 524.8K
  • Earning Date
  • IVA 03-26-2025
  • HLLY 08-06-2025
  • Dividend Yield
  • IVA N/A
  • HLLY N/A
  • EPS Growth
  • IVA N/A
  • HLLY N/A
  • EPS
  • IVA N/A
  • HLLY N/A
  • Revenue
  • IVA $14,591,573.00
  • HLLY $596,632,000.00
  • Revenue This Year
  • IVA $15.38
  • HLLY $0.08
  • Revenue Next Year
  • IVA $24.22
  • HLLY $4.60
  • P/E Ratio
  • IVA N/A
  • HLLY N/A
  • Revenue Growth
  • IVA N/A
  • HLLY N/A
  • 52 Week Low
  • IVA $1.53
  • HLLY $1.60
  • 52 Week High
  • IVA $4.05
  • HLLY $4.08
  • Technical
  • Relative Strength Index (RSI)
  • IVA 40.84
  • HLLY 62.12
  • Support Level
  • IVA $3.00
  • HLLY $1.98
  • Resistance Level
  • IVA $3.23
  • HLLY $2.10
  • Average True Range (ATR)
  • IVA 0.21
  • HLLY 0.09
  • MACD
  • IVA -0.04
  • HLLY 0.02
  • Stochastic Oscillator
  • IVA 5.08
  • HLLY 91.89

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About HLLY Holley Inc.

Holley Inc is a designer, marketer, and manufacturer of high-performance automotive aftermarket products, featuring a portfolio of iconic brands serving the car and truck industry. It offers a diversified line of performance automotive products including fuel injection systems, tuners, exhaust products, carburetors, safety equipment and various other performance automotive products. The Company's products are designed to enhance street, off-road, recreational and competitive vehicle performance through increased horsepower, torque and drivability. The company's brands include Holley, APR, MSD and Flowmaster, among others. It derives revenue from the U.S. and Italy, of which prime revenue is derived from the U.S.

Share on Social Networks: